Logo image of CUE

CUE BIOPHARMA INC (CUE) Stock Analyst Earnings Estimates

NASDAQ:CUE - Nasdaq - US22978P1066 - Common Stock - Currency: USD

0.81  +0.03 (+3.45%)

After market: 0.8 -0.01 (-1.23%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CUE revenue by date.CUE revenue by date.
1.25M
-91.63%
5.49M
339.20%
9.287M
69.16%
8.156M
-12.18%
10.1M
23.84%
20.705M
105.00%
108.98M
426.35%
306.33M
181.09%
14.902M
-95.14%
123.66M
729.82%
320.77M
159.40%
EBITDA
YoY % growth
CUE ebitda by date.CUE ebitda by date.
-52.58M
-23.86%
-51.436M
2.18%
-41.196M
19.91%
-54.322M
-31.86%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CUE ebit by date.CUE ebit by date.
-53.5M
-22.40%
-51.992M
2.82%
-41.593M
20.00%
-40.389M
2.89%
-49.945M
-23.66%
-44.844M
10.21%
32.219M
171.85%
208.26M
546.39%
-96.734M
-146.45%
-1.072M
98.89%
174.06M
16,342.85%
Operating Margin
CUE operating margin by date.CUE operating margin by date.
-4,280.00%-947.03%-447.86%-495.20%-494.50%-216.59%29.56%67.99%-649.13%-0.87%54.26%
EPS
YoY % growth
CUE eps by date.CUE eps by date.
-1.50
-7.14%
-1.11
26.00%
-0.75
32.43%
-0.60
20.55%
-0.44
26.27%
-0.49
-12.64%
0.27
155.10%
1.74
537.04%
-0.46
-126.74%
-0.47
-2.17%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.14
29.30%
-0.13
22.76%
-0.15
-16.54%
-0.08
52.47%
Revenue
Q2Q % growth
2.419M
-8.99%
2.779M
-16.70%
1.846M
17.13%
N/A
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-9.515M
8.36%
-9.151M
-2.68%
-10.031M
-4.18%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.17
32.00%
-0.15-0.02-9.77%
Q4 2024
Q2Q % growth
-0.13
55.17%
-0.160.0317.49%
Q3 2024
Q2Q % growth
-0.17
29.17%
-0.190.0212.56%
Q2 2024
Q2Q % growth
-0.20
31.03%
-0.290.0930.27%
Q1 2024
Q2Q % growth
-0.25
13.79%
-0.280.0312.23%
Q4 2023
Q2Q % growth
-0.29
23.68%
-0.28-0.01-3.28%
Q3 2023
Q2Q % growth
-0.24
22.58%
-0.350.1130.62%
Q2 2023
Q2Q % growth
-0.29
21.62%
-0.310.025.86%
Q1 2023
Q2Q % growth
-0.29
34.09%
-0.290.000.99%
Q4 2022
Q2Q % growth
-0.38
-52.00%
-0.31-0.07-21.37%
Q3 2022
Q2Q % growth
-0.31
24.39%
-0.380.0719.23%
Q2 2022
Q2Q % growth
-0.37
-12.12%
-0.430.0613.46%
Q1 2022
Q2Q % growth
-0.44
-7.32%
-0.43-0.01-1.90%
Q4 2021
Q2Q % growth
-0.25
30.56%
-0.390.1435.71%
Q3 2021
Q2Q % growth
-0.41
-20.59%
-0.39-0.02-4.09%
Q2 2021
Q2Q % growth
-0.33
13.16%
-0.420.0921.46%
Q1 2021
Q2Q % growth
-0.41
14.58%
-0.38-0.03-7.39%
Q4 2020
Q2Q % growth
-0.36 -0.35-0.01-1.84%
Q3 2020
Q2Q % growth
-0.34
-9.68%
-0.390.0512.33%
Q2 2020
Q2Q % growth
-0.38
17.39%
-0.430.0511.68%
Q1 2020
Q2Q % growth
-0.48
11.11%
-0.35-0.13-35.79%
Q4 2019
Q2Q % growth
-0.36 -0.450.0920.35%
Q3 2019
Q2Q % growth
-0.31 -0.440.1330.24%
Q2 2019
Q2Q % growth
-0.46 -0.570.1118.67%
Q1 2019
Q2Q % growth
-0.54 -0.40-0.14-33.66%
CUE Yearly EPS VS EstimatesCUE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
421K
-75.48%
1.28M-859K-67.11%
Q4 2024
Q2Q % growth
1.576M
-13.45%
1.718M-142K-8.27%
Q3 2024
Q2Q % growth
3.336M
58.86%
1.535M1.801M117.33%
Q2 2024
Q2Q % growth
2.658M
92.33%
1.302M1.356M104.15%
Q1 2024
Q2Q % growth
1.717M
818.18%
1.225M492K40.16%
Q4 2023
Q2Q % growth
1.821M
1,114.00%
1.583M238K15.03%
Q3 2023
Q2Q % growth
2.1M
2,900.00%
1.144M956K83.57%
Q2 2023
Q2Q % growth
1.382M
4,506.67%
916.575K465.425K50.78%
Q1 2023
Q2Q % growth
187K
-81.30%
1.97M-1.783M-90.51%
Q4 2022
Q2Q % growth
150K
-98.18%
104.788K45.213K43.15%
Q3 2022
Q2Q % growth
70K
-97.08%
444.733K-374.733K-84.26%
Q2 2022
Q2Q % growth
30K
-98.91%
1.143M-1.113M-97.38%
Q1 2022
Q2Q % growth
1M
-35.48%
3.085M-2.085M-67.59%
Q4 2021
Q2Q % growth
8.25M
1,618.75%
2.996M5.254M175.37%
Q3 2021
Q2Q % growth
2.4M
242.86%
1.884M516K27.39%
Q2 2021
Q2Q % growth
2.74M
153.70%
1.068M1.672M156.55%
Q1 2021
Q2Q % growth
1.55M
72.22%
591.456K958.544K162.07%
Q4 2020
Q2Q % growth
480K
-54.29%
1.346M-866K-64.34%
Q3 2020
Q2Q % growth
700K
-28.57%
1.712M-1.012M-59.11%
Q2 2020
Q2Q % growth
1.08M
1.89%
2.108M-1.028M-48.77%
Q1 2020
Q2Q % growth
900K
143.24%
1.852M-952K-51.40%
Q4 2019
Q2Q % growth
1.05M 881.73K168.27K19.08%
Q3 2019
Q2Q % growth
980K 404K576K142.57%
CUE Yearly Revenue VS EstimatesCUE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -21.74% 0% 0.84%
Revenue0% 71.08% 0% 36.48%